Invivyd (IVVD) Earnings Date & Reports

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IVVD is expected to report earnings to fall 83.36% to -2 cents per share on August 19

Q2'25

Est.

$-0.02

Q1'25

Missed

by $0.12

Q4'24

Beat

by $0.07

Q3'24

Missed

by $0.18

Q2'24

Missed

by $0.03

The last earnings report on May 15 showed earnings per share of -14 cents, missing the estimate of -1 cents. With 1.15M shares outstanding, the current market capitalization sits at 84.49M.

View a ticker or compare two or three

Compare

IVVD